Sulpiride is an antipsychotic medication of the benzamide class, sold under the brand name Dogmatil among others. Most sources call it an atypical antipsychotic, although some texts have referred to it as a typical one. It is used mainly to treat psychosis associated with schizophrenia and major depressive disorder, and in low doses it is sometimes used for anxiety and dysthymia. Chemically and clinically it is similar to amisulpride, and levosulpiride, its purified levo-isomer, is sold in some countries for similar purposes. Sulpiride is in common use in Asia, Central America, Europe, South Africa and South America, but it is not approved in the United States, Canada or Australia. That uneven approval history is part of the record here. This entry describes what is held about the drug and is not medical advice.
Facts
Classification
Approval Status Route of Administration Sources
1. ChEMBL, EMBL-EBI: ChEMBL molecule record for Sulpiride
ChEMBL, EMBL-EBImolecule record: max_phase
"max_phase": "4.0"
molecule record: oral
"oral": true
View the Source 2. RxNav RxClass, National Library of Medicine: RxClass ATC classes of Sulpiride
RxNav RxClass, National Library of MedicineRxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code N05AL (main group N)Quote, RxClass ATC class of the drug (levels 1 to 4); ATC class derived from cited code N05AL (main group N)
"classId": "N05AL", "className": "Benzamides", "classType": "ATC1-4"
View the Source Sulpiride (Wikipedia)
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.